Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia

Completed

Conditions studied: Insomnia

In brief

The present protocol will utilize simultaneous recording of brain activity during attention and memory tasks in insomnia participants after ramelteon vs. zolpidem vs. placebo administration. The investigators hypothesize that amplitudes of associated with memory will be unchanged by ramelteon, whereas zolpidem will significantly reduce brain activity associated with stimulus processing as evidenced by abnormal reduction in the amplitude of specific brain regions relative to placebo.

Key facts

Study ID

NCT00688025

Run by

Henry Ford Health System

People needed

24

Starts

2008-05-01

Expected to finish

2010-03-01

Last updated by the study team

2010-03-31

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy individuals with no secondary condition to insomnia.

You may not qualify if…

• Healthy individuals with no insomnia.

Where it is running

• Henry Ford Hospital Sleep Disorders & Research Center — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.